Voyageur Pharmaceuticals (CVE:VM) Shares Up 50% – Should You Buy?

Voyageur Pharmaceuticals Ltd. (CVE:VMGet Free Report)’s stock price rose 50% during trading on Wednesday . The stock traded as high as C$0.11 and last traded at C$0.11. Approximately 1,942,446 shares changed hands during trading, an increase of 1,795% from the average daily volume of 102,479 shares. The stock had previously closed at C$0.07.

Voyageur Pharmaceuticals Price Performance

The company has a market cap of C$14.64 million, a price-to-earnings ratio of -10.50 and a beta of 0.32. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The company has a fifty day moving average price of C$0.07 and a two-hundred day moving average price of C$0.06.

About Voyageur Pharmaceuticals

(Get Free Report)

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

Featured Articles

Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.